Hepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapy.
about
A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016Hepatocellular Carcinoma in Pakistan: National Trends and Global PerspectiveBiomarkers for the early diagnosis of hepatocellular carcinomaEpigenetic mechanisms underlying the link between non-alcoholic fatty liver diseases and nutritionGlypican-3: a marker and a therapeutic target in hepatocellular carcinomaRole of epigenetic aberrations in the development and progression of human hepatocellular carcinomaA high level of liver-specific expression of oncogenic Kras(V12) drives robust liver tumorigenesis in transgenic zebrafishEvidence of distinct tumour-propagating cell populations with different properties in primary human hepatocellular carcinomaGenome-wide transcriptional reorganization associated with senescence-to-immortality switch during human hepatocellular carcinogenesisActionable gene expression-based patient stratification for molecular targeted therapy in hepatocellular carcinomaDNA methylation: potential biomarker in Hepatocellular Carcinoma.Network-based pipeline for analyzing MS data: an application toward liver cancer.Systems biology for hepatologists.Recombinant VP1, an Akt inhibitor, suppresses progression of hepatocellular carcinoma by inducing apoptosis and modulation of CCL2 productionKPT-330 inhibitor of XPO1-mediated nuclear export has anti-proliferative activity in hepatocellular carcinoma.Chronic hepatitis B in 2014: great therapeutic progress, large diagnostic deficit.Aptamer-conjugated multifunctional nanoflowers as a platform for targeting, capture, and detection in laser desorption ionization mass spectrometry.Long non-coding RNAs: critical players in hepatocellular carcinomaDiagnostic performance of alpha-fetoprotein, lens culinaris agglutinin-reactive alpha-fetoprotein, des-gamma carboxyprothrombin, and glypican-3 for the detection of hepatocellular carcinoma: a systematic review and meta-analysis protocol.A re-emerging marker for prognosis in hepatocellular carcinoma: the add-value of fishing c-myc gene for early relapseThe value of serum midkine level in diagnosis of hepatocellular carcinoma.Hepatocellular carcinoma: clinical frontiers and perspectives.Reciprocal interaction of Wnt and RXR-α pathways in hepatocyte development and hepatocellular carcinoma.A genetic variant in primary miR-378 is associated with risk and prognosis of hepatocellular carcinoma in a Chinese population.Tissue biomarkers as predictors of outcome and selection of transplant candidates with hepatocellular carcinomaProteomic analysis of human hepatoma cells expressing methionine adenosyltransferase I/III: Characterization of DDX3X as a target of S-adenosylmethionineDNA methylation-regulated miR-193a-3p dictates resistance of hepatocellular carcinoma to 5-fluorouracil via repression of SRSF2 expression.Integrated analysis of miRNA, gene, and pathway regulatory networks in hepatic cancer stem cells.Aberrant methylation and downregulation of sall3 in human hepatocellular carcinoma.New strategies in hepatocellular carcinoma: genomic prognostic markers.Hepatocellular carcinoma: natural history, current management, and emerging tools.Osteopontin and latent-TGF β binding-protein 2 as potential diagnostic markers for HBV-related hepatocellular carcinoma.Sorafenib and hepatic arterial infusion chemotherapy for unresectable advanced hepatocellular carcinoma: A comparative studyMicroRNA-200a inhibits epithelial-mesenchymal transition in human hepatocellular carcinoma cell lineDalbinol, a rotenoid from Amorpha fruticosa L., exerts anti-proliferative activity by facilitating β-catenin degradation in hepatocellular carcinoma cells.STK33 promotes hepatocellular carcinoma through binding to c-MycDevelopment of a conditional liver tumor model by mifepristone-inducible Cre recombination to control oncogenic kras V12 expression in transgenic zebrafish.Preoperative mean corpuscular hemoglobin affecting long-term outcomes of hepatectomized patients with hepatocellular carcinoma.Hypermethylation and Expression Silencing of PDCD4 Gene in Hepatocellular Carcinoma: A Consort Study.Decreased expression of Sushi Domain Containing 2 correlates to progressive features in patients with hepatocellular carcinoma.
P2860
Q26752478-C7B77274-F9BA-43BF-9042-F5D353A8EE63Q26767217-2F92AF49-E09B-4A1B-9DBC-CBD30BCD9D72Q26784418-A3D34DE8-7510-414D-A2EC-A8AA032759AFQ26822513-0CDE5B2A-1DCD-47E0-A891-70658B8E816DQ26827487-653B7686-B450-466F-97D7-450C2050EB6AQ27023524-86A86771-6388-4775-BCFE-8EA5BED1EFD6Q28393439-67DC6D38-81A6-44F2-AA7E-24CE8BAB5B3CQ28478709-3D81CAE7-2EF0-4605-8C7C-C25AC4F08C40Q28488081-04ABC982-A092-4C57-A6F0-747C9C44972AQ31119684-CAC3D85B-BB89-49FA-8548-F00391386110Q33617129-1EAF806E-AFD3-4CF7-823E-E9B93A38ABB4Q33848303-E4106DA4-8387-4C31-9E33-BB01E0B9A248Q33927426-F3051E31-AC6C-4F7D-BB51-FD0A047858A8Q33986185-D2B2E353-A152-459B-961A-1CA972C174B4Q34098446-9FA5BCB7-35F2-4271-8D8F-DD6C0034261DQ34137291-1BF05B87-CED8-4A5C-A112-43B239C07755Q34501226-E16F8E17-9239-4B8A-AD7B-7E9754EBE554Q34685418-CD2468FC-092D-4AAE-B215-57276D0ACB1BQ34759365-AE45DE24-C8AC-4DA1-BB2A-04FEFDFCB2D1Q34847309-DB2A5F03-1408-4AE5-BF9A-769E915B7A22Q35110135-83B85416-A88B-4756-A397-9C0866A612EAQ35112053-CE6781C2-5376-4D52-969B-0DAD5BAA9421Q35147588-10FE9888-26E3-4B5D-9FF9-D46FBAD17FCFQ35153904-8E0D30F5-1355-4429-859A-E809287F576AQ35187751-59A14346-EA81-41EA-B3CE-EB7B64B7342AQ35684499-99EFD764-123D-43DB-9E93-C9A6C5A68621Q35774040-1B268F79-7E01-4562-9983-B6375192B512Q35936416-2BDFFD92-9895-4CF2-BF27-1A3F2085A2FEQ36016070-F627AE54-C920-4AF9-A436-619DB846FFA8Q36090222-3C41CF3D-87CB-4881-A522-F34D4C21F127Q36171275-051E08DF-648D-4734-9D10-FD79723E1E81Q36198665-6204E935-D411-44F8-831C-0454A7F420E8Q36230740-AA764403-C520-4ABD-95C5-FEB3CFFDF48DQ36262222-9B3993A5-31C0-4993-A872-601969FC16C5Q36382856-B32261CB-A355-4F63-BD98-06ACDD2C959AQ36475485-0E30C2D1-5440-4872-B2A8-011D3A78695CQ36501027-A4F86AEF-6547-46CC-A8C6-899159983B7EQ36523881-BEE875F7-4544-49F4-B2DC-BB0AA2620B8DQ36580984-FD1F9886-3FF5-4141-A8C7-EDA9F9CABFA7Q36634582-0CC3D72C-0186-4123-AF2B-9D63B345E57D
P2860
Hepatocellular carcinoma: novel molecular approaches for diagnosis, prognosis, and therapy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Hepatocellular carcinoma: nove ...... nosis, prognosis, and therapy.
@en
type
label
Hepatocellular carcinoma: nove ...... nosis, prognosis, and therapy.
@en
prefLabel
Hepatocellular carcinoma: nove ...... nosis, prognosis, and therapy.
@en
P2093
P2860
P1476
Hepatocellular carcinoma: nove ...... nosis, prognosis, and therapy.
@en
P2093
Alejandro Forner
Augusto Villanueva
Beatriz Minguez
Maria Reig
P2860
P304
P356
10.1146/ANNUREV.MED.080608.100623
P577
2010-01-01T00:00:00Z